Apple Tree Partners

Summary

Apple Tree Partners appeared to be the VC, which was created in 1999. The venture was found in North America in United States. The main department of described VC is located in the New York.

The fund has exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Therapeutics, Biopharma. Among the most popular portfolio startups of the fund, we may highlight Syntimmune, Chinook Therapeutics, Corvidia. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Besides them, we counted 4 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Apple Tree Partners, startups are often financed by Novartis Venture Fund, SR One, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are SR One, Roche Venture Fund, Partners Innovation Fund. In the next rounds fund is usually obtained by Novartis Venture Fund, SR One, Roche Venture Fund.

The top activity for fund was in 2014. Opposing the other organizations, this Apple Tree Partners works on 3 percentage points less the average amount of lead investments. When the investment is from Apple Tree Partners the average startup value is 10-50 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. Considering the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually.